2020 Plenary Keynote: Tackling Undruggable Oncoproteins: Lessons from the VHL Tumor Suppressor Protein
William G. Kaelin, Jr., MD
2019 Nobel Laureate; Sidney Farber Professor of Medicine, Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School; Investigator, Howard Hughes Medical Institute (Co-Founder, Cedilla Therapeutics and Co-Founder, Tango Therapeutics)
Dr. Kaelin received the 2019 Nobel Prize in Physiology or Medicine. Dr. Kaelin is a member of the American Society of Clinical Investigation, the American College of Physicians, the National Academy of Sciences and the National Academy of
PANEL DISCUSSION: De-Risking Early Drug Discovery
Moderator: Nadeem Sarwar, PhD
Founder & President, Eisai Center for Genetics Guided Dementia Discovery, Eisai, Inc.
Anthony A. Philippakis, PhD
Chief Data Officer, Data Sciences & Data Engineering, Broad Institute, Venture Partner, GV
Stephen A. Hitchcock, PhD
Head, Research, Takeda Pharmaceuticals, Inc.